LATEST NEWS

Recent Articles from TheStreet

Failing Hibbett Sports Just Tossed Serious Shade on Under Armour's Lack of Cool

Five Top Stock Gainers for Tuesday: Under Armour, ZoomInfo, Translate Bio

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Camping World Lead

Camping World Stock Slips After Mixed Earnings Report

Camping World's revenue jumped 28% to $2.06 billion in the second quarter but trailed analysts’ consensus estimate.

Outlook Therapeutics Lead

Outlook Therapeutics Stock Soars on Positive Results for Eye Treatment

Outlook Therapeutics plans to submit an application to the Food and Drug Administration.

Fidelity National Information Services Lead

Fidelity National Information Services Stock Drops as Guidance Lags

Fidelity National Information Services raised its guidance for the second time this year, but third-quarter expectations are below analyst estimates.

Nvidia Lead

Nvidia Stock Rises; J.P. Morgan Lifts Target on PC Gaming Potential

Nvidia 'continues to execute across all segments,' J.P. Morgan analyst Harlan Sur said, lifting his price target to $215 from $176.

KKR Bulls Seek, Find Quick Yield

KKR Stock at 52-Week High After Earnings Beat and Record Inflows

Private-equity icon KKR reported second-quarter earnings beat Wall Street estimates and asset inflows touched a record.

Activision Lead

Blizzard Entertainment President Stepping Down Amid Lawsuit

J. Allen Brack is leaving Blizzard 'to pursue new opportunities,' the company says.

Watch Jim Cramer Live 8/3/21

Video: Jim Cramer on Clorox, Under Armour, BP, DuPont, Eli Lilly, COVID

Jim Cramer discusses COVID market sentiment, Under Armour, BP, DuPont, Eli Lilly and more in Tuesday's video interview with TheStreet Live.

Corsair Lead

Corsair Gaming Stock Lower After Profit Misses Estimate

Corsair Gaming shares fell after the videogame-equipment company reported weaker-than-expected second-quarter earnings.

NYSE Trader Lead

Stocks Push Higher as Earnings Outweigh Worries About COVID and China's Clampdown

Stocks waver amid jitters about the spread of COVID-19's delta variant and China's clampdown on its gaming and technology sectors.